{
  "symbol": "AFL",
  "year": 2023,
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.1864,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.085
  },
  "top_positive": [
    {
      "sent": "Financial Statements and Supplementary Data Consolidated Balance Sheet December 31, 2022 (In millions) As Reported Adoption Impacts As Adjusted Assets: Investments and cash: Fixed maturity securities available for sale, at fair value $ 71,936 $ 0 $ 71,936 Fixed maturity securities available for sale - consolidated variable interest entities, at fair value 3,805 0 3,805 Fixed maturity securities held to maturity, at amortized cost, net of allowance for credit losses 19,056 0 19,056 Equity securities, at fair value 1,091 0 1,091 Commercial mortgage and other loans, net of allowance for credit losses 13,496 0 13,496 Other investments 4,070 0 4,070 Cash and cash equivalents 3,943 0 3,943 Total investments and cash 117,397 0 117,397 Receivables 647 0 647 Accrued investment inc\nsumption, which will result in an increase in the deferred profit liability on limited-payment products compared to current guidance.",
      "score": 0.979
    },
    {
      "sent": "Financial Statements and Supplementary Data Consolidated Balance Sheet December 31, 2022 (In millions) As Reported Adoption Impacts As Adjusted Assets: Investments and cash: Fixed maturity securities available for sale, at fair value $ 71,936 $ 0 $ 71,936 Fixed maturity securities available for sale - consolidated variable interest entities, at fair value 3,805 0 3,805 Fixed maturity securities held to maturity, at amortized cost, net of allowance for credit losses 19,056 0 19,056 Equity securities, at fair value 1,091 0 1,091 Commercial mortgage and other loans,\nvel basis used will be units in force, which is a proxy for face amount and insurance in force, respectively.",
      "score": 0.9769
    },
    {
      "sent": "Financial Statements and Supplementary Data Consolidated Balance Sheet December 31, 2022 (In millions) As Reported Adoption Impacts As Adjusted Assets: Investments and cash: Fixed maturity securities available for sale, at fair value $ 71,936 $ 0 $ 71,936 Fixed maturity securities available for sale - consolidated variable interest entities, at fair value 3,805 0 3,805 Fixed maturity securities held to maturity, at amortized cost, net of allowance for credit losses 19,056 0 19,056 Equity securities, at fair value 1,091 0 1,091 Commercial mortgage and other loans, net of allowance for credit losses 13,496 0 13,496 Other investments 4,070 0 4,070 Cash and cash equivalents 3,943 0 3,943 Total investments and cash 117,397 0 117,397 Receivables 647 0 647 Accrued investment income 745 0 745 Deferred policy acquisition costs (1) 8,593 646 9,239 Property and equipment 530 0 530 Other (2) 3,105 75 3,180 Total assets $ 131,017 $ 721 $ 131,738 Liabilities and shareholders\u2019 equity: Liabilities: Policy liabilities: Future policy benefits (3),(4),(5) $ 80,749 $ 7,492 $ 88,241 Unpaid policy claims (3),(6) 4,561 ( 4,360 ) 201 Unearned premiums 1,825 0 1,825 Other policyholders\u2019 funds (6) 6,123 520 6,643 Total policy liabilities 93,258 3,652 96,910 Income taxes (7) 1,296 ( 598 ) 698 Payables for return of cash collateral on loaned securities 1,809 0 1,809 Notes payable and lease obligations 7,442 0 7,442 Other (4) 4,847 ( 108 ) 4,739 Total liabilities\n claims to other policyholders' funds.",
      "score": 0.9709
    }
  ],
  "top_negative": [
    {
      "sent": "Third Sector Insurance Products Cancer Cancer Insurance Aflac Japan pioneered the cancer insurance market in Japan in 1974, and remains the number one provider of cancer insurance in Japan today.",
      "score": -0.9601
    },
    {
      "sent": "Third Sector Insurance Products Cancer Cancer Insurance Aflac Japan pioneered the cancer insurance market in Japan in 1974, and remains the number one provider of cancer insurance in Japan today.",
      "score": -0.9601
    },
    {
      "sent": "Medical and Other Health Medical Insurance Aflac Japan's medical insurance products provide benefits for hospitalization, surgeries and outpatient treatment of various illnesses, as well as lump sum benefits related to three critical illnesses: cancer, heart attack, and stroke.",
      "score": -0.872
    }
  ],
  "forward_snippets": [
    "\u2022 expect \u2022 anticipate \u2022 believe \u2022 goal \u2022 objective \u2022 may \u2022 should \u2022 estimate \u2022 intends \u2022 projects \u2022 will \u2022 assumes \u2022 potential \u2022 target \u2022 outlook The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: \u2022 difficult conditions in global capital markets and the economy, including those caused by COVID-19 \u2022 defaults and credit downgrades of investments \u2022 global fluctuations in interest rates and exposure to significant interest rate risk \u2022 concentration of business in Japan \u2022 limited availability of acceptable yen-denominated investments \u2022 foreign currency fluctuations in the yen/dollar exchange rate \u2022 differing interpretations applied to investment valuations \u2022 significant valuation judgments in determination of expected credit losses recorded on the Company's investments \u2022 decreases in the Company's financial strength or debt ratings \u2022 decline in creditworthiness of other financial institutions \u2022 concentration of the Company's investments in any particular single-issuer or sector \u2022 major public health issues, including COVID-19 and any resulting or coincidental economic effects, on the Company's business and financial results \u2022 the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners \u2022 deviations in actual experience from pricing and reserving assumptions \u2022 ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives \u2022 interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems \u2022 subsidiaries' ability to pay dividends to the Parent Company \u2022 inherent limitations to risk management policies and procedures \u2022 operational risks of third party vendors \u2022 tax rates applicable to the Company may change \u2022 failure to comply with restrictions on policyholder privacy and information security \u2022 extensive regulation and changes in law or regulation by governmental authorities \u2022 competitive environment and ability to anticipate and respond to market trends \u2022 catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events \u2022 ability to protect the Aflac brand and the Company's reputation \u2022 ability to effectively manage key executive succession \u2022 changes in accounting standards \u2022 level and outcome of litigation \u2022 allegations or determinations of worker misclassification in the United States 1 Item 1.",
    "\u2022 expect \u2022 anticipate \u2022 believe \u2022 goal \u2022 objective \u2022 may \u2022 should \u2022 estimate \u2022 intends \u2022 projects \u2022 will \u2022 assumes \u2022 potential \u2022 target \u2022 outlook The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: \u2022 difficult conditions in global capital markets and the economy, including those caused by COVID-19 \u2022 defaults and credit downgrades of investments \u2022 global fluctuations in interest rates and exposure to significant interest rate risk \u2022 concentration of business in Japan \u2022 limited availability of acceptable yen-denominated investments \u2022 foreign currency fluctuations in the yen/dollar exchange rate \u2022 differing interpretations applied to investment valuations \u2022 significant valuation judgments in determination of expected credit losses recorded on the Company's investments \u2022 decreases in the Company's financial strength or debt ratings \u2022 decline in creditworthiness of other financial institutions \u2022 concentration of the Company's investments in any particular single-issuer or sector \u2022 major public health issues, including COVID-19 and any resulting or coincidental economic effects, on the Company's business and financial results \u2022 the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners \u2022 deviations in actual experience from pricing and reserving assumptions \u2022 ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives \u2022 interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems \u2022 subsidiaries' ability to pay dividends to the Parent Company \u2022 inherent limitations to risk management policies and procedures \u2022 operational risks of third party vendors \u2022 tax rates applicable to the Company may change \u2022 failure to comply with restrictions on policyholder privacy and information security \u2022 extensive regulation and changes in law or regulation by governmental authorities \u2022 competitive environment and ability to anticipate and respond to market trends \u2022 catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events \u2022 ability to protect the Aflac brand and the Company's reputation \u2022 ability to effectively manage key executive succession \u2022 changes in accounting standards \u2022 level and outcome of litigation \u2022 allegations or determinations of worker misclassification in the United States 1 Item 1.",
    "\u2022 expect \u2022 anticipate \u2022 believe \u2022 goal \u2022 objective \u2022 may \u2022 should \u2022 estimate \u2022 intends \u2022 projects \u2022 will \u2022 assumes \u2022 potential \u2022 target \u2022 outlook The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: \u2022 difficult conditions in global capital markets and the economy, including those caused by COVID-19 \u2022 defaults and credit downgrades of investments \u2022 global fluctuations in interest rates and exposure to significant interest rate risk \u2022 concentration of business in Japan \u2022 limited availability of acceptable yen-denominated investments \u2022 foreign currency fluctuations in the yen/dollar exchange rate \u2022 differing interpretations applied to investment valuations \u2022 significant valuation judgments in determination of expected credit losses recorded on the Company's investments \u2022 decreases in the Company's financial strength or debt ratings \u2022 decline in creditworthiness of other financial institutions \u2022 concentration of the Company's investments in any particular single-issuer or sector \u2022 major public health issues, including COVID-19 and any resulting or coincidental economic effects, on the Company's business and financial results \u2022 the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners \u2022 deviations in actual experience from pricing and reserving assumptions \u2022 ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives \u2022 interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems \u2022 subsidiaries' ability to pay dividends to the Parent Company \u2022 inherent limitations to risk management policies and procedures \u2022 operational risks of third party vendors \u2022 tax rates applicable to the Company may change \u2022 failure to comply with restrictions on policyholder privacy and information security \u2022 extensive regulation and changes in law or regulation by governmental authorities \u2022 competitive environment and ability to anticipate and respond to market trends \u2022 catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events \u2022 ability to protect the Aflac brand and the Company's reputation \u2022 ability to effectively manage key executive succession \u2022 changes in accounting standards \u2022 level and outcome of litigation \u2022 allegations or determinations of worker misclassification in the United States 1 Item 1.",
    "\u2022 expect \u2022 anticipate \u2022 believe \u2022 goal \u2022 objective \u2022 may \u2022 should \u2022 estimate \u2022 intends \u2022 projects \u2022 will \u2022 assumes \u2022 potential \u2022 target \u2022 outlook The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: \u2022 difficult conditions in global capital markets and the economy, including those caused by COVID-19 \u2022 defaults and credit downgrades of investments \u2022 global fluctuations in interest rates and exposure to significant interest rate risk \u2022 concentration of business in Japan \u2022 limited availability of acceptable yen-denominated investments \u2022 foreign currency fluctuations in the yen/dollar exchange rate \u2022 differing interpretations applied to investment valuations \u2022 significant valuation judgments in determination of expected credit losses recorded on the Company's investments \u2022 decreases in the Company's financial strength or debt ratings \u2022 decline in creditworthiness of other financial institutions \u2022 concentration of the Company's investments in any particular single-issuer or sector \u2022 major public health issues, including COVID-19 and any resulting or coincidental economic effects, on the Company's business and financial results \u2022 the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners \u2022 deviations in actual experience from pricing and reserving assumptions \u2022 ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives \u2022 interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems \u2022 subsidiaries' ability to pay dividends to the Parent Company \u2022 inherent limitations to risk management policies and procedures \u2022 operational risks of third party vendors \u2022 tax rates applicable to the Company may change \u2022 failure to comply with restrictions on policyholder privacy and information security \u2022 extensive regulation and changes in law or regulation by governmental authorities \u2022 competitive environment and ability to anticipate and respond to market trends \u2022 catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events \u2022 ability to protect the Aflac brand and the Company's reputation \u2022 ability to effectively manage key executive succession \u2022 changes in accounting standards \u2022 level and outcome of litigation \u2022 allegations or determinations of worker misclassification in the United States 1 Item 1.",
    "In November 2020, the Company, through its insurance sub\noutlook The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: \u2022 difficult conditions in global capital markets and the economy, including those caused by COVID-19 \u2022 defaults and credit downgrades of investments \u2022 global fluctuations in interest rates and exposure to significant interest rate risk \u2022 concentration of business in Japan \u2022 limited availability of acceptable yen-denominated investments \u2022 foreign currency fluctuations in the yen/dollar exchange rate \u2022 differing interpretations applied to investment valuations \u2022 significant valuation judgments in determination of expected credit losses recorded on the Company's investments \u2022 decreases in the Company's financial strength or debt ratings \u2022 decline in creditworthiness of other financial institutions \u2022 concentration of the Company's investments in any particular single-issuer or sector \u2022 major public health issues, including COVID-19 and any resulting or coincidental economic effects, on the Company's business and financial results \u2022 the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners \u2022 deviations in actual experience from pricing and reserving assumptions \u2022 ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives \u2022 interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems \u2022 subsidiaries' ability to pay dividends to the Parent Company \u2022 inherent limitations to risk management policies and procedures \u2022 operational risks of third party vendors \u2022 tax rates applicable to the Company may change \u2022 failure to comply with restrictions on policyholder privacy and information security \u2022 extensive regulation and changes in law or regulation by governmental authorities \u2022 competitive environment and ability to anticipate and respond to market trends \u2022 catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events \u2022 ability to protect the Aflac brand and the Company's reputation \u2022 ability to effectively manage key executive succession \u2022 changes in accounting standards \u2022 level and outcome of litigation \u2022 allegations or determinations of worker misclassification in the United States 1 Item 1."
  ]
}